Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Free Cash Flow Generation Index
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Free Cash Flow Generation Index of -0.83x as of September 2025. Free cash flow of CN¥-32.78 Million represents -1% of operating cash flow (CN¥39.68 Million). Read Xizang Haisco Pharmaceutical Group Co Lt total liabilities for a breakdown of total debt and financial obligations.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Free Cash Flow Generation Index (2008–2025)
Historical FCF Generation Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. Explore Xizang Haisco Pharmaceutical Group Co Lt capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year Free Cash Flow Generation Index for Xizang Haisco Pharmaceutical Group Co Ltd. For the full company profile including market capitalisation, see market cap of Xizang Haisco Pharmaceutical Group Co Lt.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.58x | CN¥454.03 Million | CN¥786.00 Million | CN¥331.98 Million | ▲ +18255.3% |
| 2024 | 0.00x | CN¥1.39 Million | CN¥442.05 Million | CN¥440.65 Million | ▼ -97.6% |
| 2023 | 0.13x | CN¥58.57 Million | CN¥449.58 Million | CN¥391.01 Million | ▲ +102.0% |
| 2022 | -6.41x | CN¥-605.62 Million | CN¥94.55 Million | CN¥700.17 Million | ▲ +65.6% |
| 2021 | -18.63x | CN¥-667.14 Million | CN¥35.80 Million | CN¥702.94 Million | ▼ -871.5% |
| 2020 | -1.92x | CN¥-395.51 Million | CN¥206.21 Million | CN¥601.72 Million | ▼ -907.3% |
| 2019 | 0.24x | CN¥181.58 Million | CN¥764.26 Million | CN¥582.68 Million | ▼ -6.9% |
| 2018 | 0.26x | CN¥120.62 Million | CN¥472.61 Million | CN¥351.98 Million | ▲ +7008.0% |
| 2017 | 0.00x | CN¥-1.45 Million | CN¥391.81 Million | CN¥393.26 Million | ▼ -100.7% |
| 2016 | 0.53x | CN¥217.87 Million | CN¥409.20 Million | CN¥208.24 Million | ▲ +48.0% |
| 2015 | 0.36x | CN¥159.35 Million | CN¥443.03 Million | CN¥283.68 Million | ▼ -32.5% |
| 2014 | 0.53x | CN¥267.71 Million | CN¥502.57 Million | CN¥234.86 Million | ▼ -25.1% |
| 2013 | 0.71x | CN¥404.43 Million | CN¥568.41 Million | CN¥163.98 Million | ▼ -2.6% |
| 2012 | 0.73x | CN¥339.45 Million | CN¥464.75 Million | CN¥125.30 Million | ▲ +33.1% |
| 2011 | 0.55x | CN¥143.07 Million | CN¥260.79 Million | CN¥117.72 Million | ▼ -29.6% |
| 2010 | 0.78x | CN¥286.43 Million | CN¥367.38 Million | CN¥80.95 Million | ▼ -16.6% |
| 2009 | 0.93x | CN¥344.21 Million | CN¥368.21 Million | CN¥24.01 Million | ▲ +54.7% |
| 2008 | 0.60x | CN¥57.07 Million | CN¥94.45 Million | CN¥37.38 Million | — |